Insider sale
ADAPTIMMUNE THERAPEUTICS PLC
$981.9K
13.83M shares
What this filing means
NEW ENTERPRISE ASSOCIATES 14, L.P. plans to sell 13.83M shares of ADAPTIMMUNE THERAPEUTICS PLC valued at approximately $981.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/15/2025ACC: 0001968582-25-000747
10% Owner
Since Sep 2018
13.83M
Shares to sell
$981.9K
Approx. market value
13.83M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months8
Private Placement
Cash
9/5/2018
500KPrivate Placement
Cash
3/27/2018
1MPrivate Placement
Cash
3/26/2018
95.19KPrivate Placement
Cash
3/23/2018
49.02KPrivate Placement
Cash
3/22/2018
144.93KPrivate Placement
Cash
3/21/2018
17.47KPrivate Placement
Cash
3/22/2017
2.15MPrivate Placement
Cash
9/23/2014
9.88MTotal acquired13.83M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/5/2018 | Private Placement Cash | 500K | — |
3/27/2018 | Private Placement Cash | 1M | — |
3/26/2018 | Private Placement Cash | 95.19K | — |
3/23/2018 | Private Placement Cash | 49.02K | — |
3/22/2018 | Private Placement Cash | 144.93K | — |
3/21/2018 | Private Placement Cash | 17.47K | — |
3/22/2017 | Private Placement Cash | 2.15M | — |
9/23/2014 | Private Placement Cash | 9.88M | — |
| Total | 13.83M | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
13.83M
Market value
$981.9K
8/15/2025
Total
Units
13.83M
Value
$981.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/15/2025 | 13.83M | $981.9K | NASDAQ | Planned |
| Total | 13.83M | $981.9K | ||